BNP Paribas Financial Markets’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13 | Buy |
+8
| New | +$13 | ﹤0.01% | 4587 |
|
|
2024
Q3 | – | Sell |
-24
| Closed | -$18 | – | 3456 |
|
|
2024
Q2 | $18 | Hold |
24
| – | – | ﹤0.01% | 3330 |
|
|
2024
Q1 | $25 | Hold |
24
| – | – | ﹤0.01% | 3325 |
|
|
2023
Q4 | $25 | Sell |
24
-35
| -59% | -$36 | ﹤0.01% | 3260 |
|
|
2023
Q3 | $66 | Hold |
59
| – | – | ﹤0.01% | 3181 |
|
|
2023
Q2 | $89 | Sell |
59
-588
| -91% | -$887 | ﹤0.01% | 3238 |
|
|
2023
Q1 | $1.01K | Sell |
647
-562
| -46% | -$876 | ﹤0.01% | 3053 |
|
|
2022
Q4 | $771 | Sell |
1,209
-206,058
| -99% | -$131K | ﹤0.01% | 3169 |
|
|
2022
Q3 | $276K | Sell |
207,267
-78,256
| -27% | -$104K | ﹤0.01% | 2647 |
|
|
2022
Q2 | $634K | Sell |
285,523
-43,313
| -13% | -$96.2K | ﹤0.01% | 1942 |
|
|
2022
Q1 | $2.04M | Buy |
328,836
+149,223
| +83% | +$924K | ﹤0.01% | 1360 |
|
|
2021
Q4 | $2.27M | Buy |
179,613
+176,025
| +4,906% | +$2.22M | ﹤0.01% | 1423 |
|
|
2021
Q3 | $329K | Buy |
3,588
+2,851
| +387% | +$261K | ﹤0.01% | 2326 |
|
|
2021
Q2 | $39.1K | Sell |
737
-2,436
| -77% | -$129K | ﹤0.01% | 2759 |
|
|
2021
Q1 | $114K | Sell |
3,173
-3,800
| -54% | -$137K | ﹤0.01% | 2740 |
|
|
2020
Q4 | $194K | Buy |
6,973
+3,242
| +87% | +$90.1K | ﹤0.01% | 2264 |
|
|
2020
Q3 | $187K | Buy |
3,731
+3,053
| +450% | +$153K | ﹤0.01% | 2193 |
|
|
2020
Q2 | $31.4K | Sell |
678
-2,795
| -80% | -$129K | ﹤0.01% | 2595 |
|
|
2020
Q1 | $158K | Buy |
3,473
+1,922
| +124% | +$87.7K | ﹤0.01% | 2379 |
|
|
2019
Q4 | $87.1K | Buy |
1,551
+1,186
| +325% | +$66.6K | ﹤0.01% | 2696 |
|
|
2019
Q3 | $9.1K | Buy |
365
+351
| +2,507% | +$8.75K | ﹤0.01% | 3525 |
|
|
2019
Q2 | $595 | Buy |
+14
| New | +$595 | ﹤0.01% | 3766 |
|